StockData
CV Sciences, Inc. logo

CV Sciences, Inc. (CVSI) stock

CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)

Close on Oct 19, 2026Market cap $2.53MP/E –Yield –

CV Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CV Sciences's operating income for the twelve months ending Sep 30, 2026 was -$317.00K. For fiscal 2025 it was -$470.00K. The highest annual figure on record is $10.25M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$470.00K–
FY2024Dec 31, 2024-$2.19M-165.2%
FY2023Dec 31, 2023$3.36M–
FY2022Dec 31, 2022-$6.85M–
FY2021Dec 31, 2021-$18.45M–
FY2020Dec 31, 2020-$22.59M–
FY2019Dec 31, 2019-$17.24M-268.2%
FY2018Dec 31, 2018$10.25M–
FY2017Dec 31, 2017-$4.86M–
FY2016Dec 31, 2016-$13.07M–
FY2015Dec 31, 2015-$11.21M–
FY2014Dec 31, 2014-$8.55M–
FY2013Dec 31, 2013-$1.62M–
FY2012Dec 31, 2012-$43.02K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$377.00K–
Q2 FY2026Jun 30, 2026-$301.00K–
Q1 FY2026Mar 31, 2026-$318.00K-2990.9%
Q4 FY2025Dec 31, 2025-$75.00K–
Q3 FY2025Sep 30, 2025-$275.00K–
Q2 FY2025Jun 30, 2025-$131.00K–
Q1 FY2025Mar 31, 2025$11.00K–
Q4 FY2024Dec 31, 2024-$646.00K–
Q3 FY2024Sep 30, 2024-$341.00K–
Q2 FY2024Jun 30, 2024-$583.00K–
Q1 FY2024Mar 31, 2024-$620.00K-110.8%
Q4 FY2023Dec 31, 2023-$889.00K–
Q3 FY2023Sep 30, 2023-$437.00K–
Q2 FY2023Jun 30, 2023-$1.08M–
Q1 FY2023Mar 31, 2023$5.76M–
Q4 FY2022Dec 31, 2022-$2.13M–
Q3 FY2022Sep 30, 2022-$892.00K–
Q2 FY2022Jun 30, 2022-$2.32M–
Q1 FY2022Mar 31, 2022-$1.52M–
Q4 FY2021Dec 31, 2021-$8.84M–
Q3 FY2021Sep 30, 2021-$2.98M–
Q2 FY2021Jun 30, 2021-$3.51M–
Q1 FY2021Mar 31, 2021-$3.11M–
Q4 FY2020Dec 31, 2020-$9.46M–
Q3 FY2020Sep 30, 2020-$3.15M–
Q2 FY2020Jun 30, 2020-$4.66M-471.4%
Q1 FY2020Mar 31, 2020-$5.32M–
Q4 FY2019Dec 31, 2019-$7.34M-366.3%
Q3 FY2019Sep 30, 2019-$1.77M-150.3%
Q2 FY2019Jun 30, 2019$1.25M-62.0%
Q1 FY2019Mar 31, 2019-$9.38M-1503.9%
Q4 FY2018Dec 31, 2018$2.76M+1938.1%
Q3 FY2018Sep 30, 2018$3.53M–
Q2 FY2018Jun 30, 2018$3.30M–
Q1 FY2018Mar 31, 2018$668.00K–
Q4 FY2017Dec 31, 2017$135.28K–
Q3 FY2017Sep 30, 2017-$481.78K–
Q2 FY2017Jun 30, 2017-$859.67K–
Q1 FY2017Mar 31, 2017-$3.65M–
Q4 FY2016Dec 31, 2016-$8.23M–

More CV Sciences figures

See a number that looks wrong?